次髎穴埋线治疗脊髓损伤后神经源性肠道功能障碍(便秘型)的临床研究OACSTPCD

Objective To observe the clinical efficacy of catgut embedding at Ciliao(BL32)in treating neurogenic bowel dysfunction(constipation type)after spinal cord injury.Method Seventy-four patients with neurogenic bowel dysfunction(constipation type)after spinal cord injury were randomly divided into a research group with 38 cases and a control group with 36 cases.Besides the conventional treatment,the research group also received catgut embedding at Ciliao,and the control group received oral lactulose for treatment.Before and after the treatment,the two groups were compared in terms of defecation frequency,defecation time,Wexner constipation score,neurogenic bowel dysfunction(NBD)score,and patient-assessment of constipation quality of life(PAC-QOL)scores.The complication rate was also evaluated.Result After the treatment,both groups showed an increased defecation frequency,shortened defecation time,and reduced PAC-QOL scores,all presenting statistical significance(P＜0.05).After the treatment,the two groups had significant differences in the defecation frequency,defecation time,and PAC-QOL scores(P＜0.05).After 2 and 4 weeks of treatment,the Wexner constipation and NBD scores dropped significantly in both groups compared to the baseline(P＜0.05);the Wexner constipation and NBD scores were significantly lower in the research group than in the control group(P＜0.05).The complication rate during the treatment was 5.3%in the research group versus 5.6%in the control group,and the difference was statistically insignificant(P＞0.05).Conclusion Catgut embedding at Ciliao can increase defecation frequency,shorten defeca-tion time,improve bowel dysfunction and constipation symptoms,and enhance the quality of life in patients with neurogenic bowel dysfunction(constipation type)after spinal cord injury with a good safety rating.